Process / pipelineBone assessment

DEXA

Dual-Energy X-ray Absorptiometry (DEXA or DXA) is a non-invasive imaging technique that quantifies bone mineral density (BMD) by measuring the attenuation of X-rays at two different energies as they pass through bone and soft tissue. First developed by Wahner and colleagues in 1987, DEXA has become the gold standard for osteoporosis screening and fracture risk assessment. It is recommended by the World Health Organization for diagnosing osteoporosis and monitoring treatment response.

Open in MethodMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Kanis, J. A. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series, 843, 1-129. link
  2. Genant, H. K., Engelke, K., Fuerst, T., et al. (1996). Noninvasive assessment of bone mineral and structure: state of the art. Journal of Bone and Mineral Research, 11(6), 707-730. DOI: 10.1002/jbmr.5650110602
  3. Blake, G. M., Fogelman, I. (2016). The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgraduate Medical Journal, 83(980), 509-517. DOI: 10.1136/pgmj.2007.057505

Related methods

Referenced by

ScholarGateDEXA (Dual-Energy X-ray Absorptiometry). Retrieved 2026-06-04 from https://scholargate.app/en/medical-imaging/dexa